Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells

被引:170
作者
Karlsson, AC
Martin, JN
Younger, SR
Bredt, BM
Epling, L
Ronquillo, R
Varma, A
Deeks, SG
McCune, JM
Nixon, DF
Sinclair, E
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, San Francisco Gen Hosp, Gen Clin Res Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA
[5] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[6] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94110 USA
关键词
HIV-1; CMV; cellular immune responses; CD4(+) and CD8(+) T cells; ELISPOT; intracellular cytokine flow cytometry;
D O I
10.1016/j.jim.2003.09.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The enumeration of antigen-specific T cell responses has been greatly facilitated in recent years by the development of methods based on the detection of cytokines. In particular, the enzyme-linked immunospot (ELISPOT) and cytokine flow cytometry (CFC) assays have become popular. Since both assays are likely to continue to be in widespread use, it is important to evaluate whether their results are comparable. In the current study, we compared the results obtained in the ELISPOT and CFC assays using peptide pools corresponding to CMV and HIV-1 proteins in chronically HIV-1-infected individuals. Analysis of T cell responses to peptide pools indicated that the CMV pp65 and HIN-1 Gag CFC and ELISPOT-derived results were statistically correlated. However, the results obtained with each assay differed in important ways: the magnitude of the response was consistently higher in the CFC assay while the CFC assay was less likely than the ELISPOT assay to detect low-level responses. Furthermore, there was a lack of numeric agreement between ELISPOT and CFC results. For studies that require the detection of low-level responses, or definition of responses as positive or negative, the ELISPOT assay may be preferable. In contrast, the CFC has a greater dynamic range and allows for phenotypic discrimination of responding cells, making it the assay of choice for most other applications. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 153
页数:13
相关论文
共 32 条
[1]   Flow cytometric determination of intracellular or secreted IFNγ for the quantification of antigen reactive T cells [J].
Asemissen, AM ;
Nagorsen, D ;
Keilholz, U ;
Letsch, A ;
Schmittel, A ;
Thiel, E ;
Scheibenbogen, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 251 (1-2) :101-108
[2]  
BENNINK JR, 1990, CURR TOP MICROBIOL, V163, P153
[3]   Putative immunodominant human immunodeficiency virus-specific CD8+ T-Cell responses cannot be predicted by major histocompatibility complex class I haplotype [J].
Betts, MR ;
Casazza, JP ;
Patterson, BA ;
Waldrop, S ;
Trigona, W ;
Fu, TM ;
Kern, F ;
Picker, LJ ;
Koup, RA .
JOURNAL OF VIROLOGY, 2000, 74 (19) :9144-9151
[4]   Monitoring HIV-specific CD8+T cell responses by intracellular cytokine production [J].
Betts, MR ;
Casazza, JP ;
Koup, RA .
IMMUNOLOGY LETTERS, 2001, 79 (1-2) :117-125
[5]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991
[6]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[7]  
BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
[8]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[9]   A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays [J].
Currier, JR ;
Kuta, EG ;
Turk, E ;
Earhart, LB ;
Loomis-Price, L ;
Janetzki, S ;
Ferrari, G ;
Birx, DL ;
Cox, JH .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) :157-172
[10]   REVERSE ELISPOT ASSAY FOR CLONAL ANALYSIS OF CYTOKINE PRODUCTION .1. ENUMERATION OF GAMMA-INTERFERON-SECRETING CELLS [J].
CZERKINSKY, C ;
ANDERSSON, G ;
EKRE, HP ;
NILSSON, LA ;
KLARESKOG, L ;
OUCHTERLONY, O .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 110 (01) :29-36